Addus HomeCare (NASDAQ:ADUS) posted its quarterly earnings data on Sunday. The company reported $0.74 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.74, MarketWatch Earnings reports. The company had revenue of $205.30 million for the quarter, compared to the consensus estimate of $209.70 million. Addus HomeCare had a return on equity of 8.90% and a net margin of 4.65%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.77 EPS.
Shares of Addus HomeCare stock traded down $6.36 on Tuesday, reaching $98.71. 9,939 shares of the company were exchanged, compared to its average volume of 87,522. Addus HomeCare has a fifty-two week low of $73.79 and a fifty-two week high of $129.01. The company has a quick ratio of 3.19, a current ratio of 3.19 and a debt-to-equity ratio of 0.12. The stock has a fifty day moving average price of $107.10 and a 200-day moving average price of $109.29.
Separately, Zacks Investment Research downgraded shares of Addus HomeCare from a “hold” rating to a “sell” rating in a report on Monday.
In other news, COO W Bradley Bickham sold 2,424 shares of the business’s stock in a transaction that occurred on Wednesday, March 3rd. The shares were sold at an average price of $102.33, for a total transaction of $248,047.92. Also, CEO R Dirk Allison sold 5,539 shares of the company’s stock in a transaction that occurred on Wednesday, March 3rd. The shares were sold at an average price of $102.09, for a total transaction of $565,476.51. Over the last ninety days, insiders have sold 11,888 shares of company stock valued at $1,223,430. 6.90% of the stock is currently owned by company insiders.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading: How a Strangle Strategy is different from a Straddle Strategy
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.